In the present study, there were no significant differences in serum IL-1β levels between normal-weight patients with MDD and overweight patients with MDD, suggesting that overweight may not be associated with serum IL-1β levels in patients with first-episode drug-naïve MDD. Here, IL1B is linked to major depressive disorder.